6 Final report of a phase III randomized trial of amifostine as a radioprotectant in head and neck cancer
- 1 January 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (3) , 147-148
- https://doi.org/10.1016/s0360-3016(99)90024-x